Additional Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury

NCT07722962 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Spinal Cord Injury (SCI)

Interventions

DRUG: KP-100IT

Sponsor

Kringle Pharma, Inc.